CDK2AP1
Cyclin-dependent kinase 2-associated protein 1
Also known as: CDKA1_HUMAN, doc-1, DOC1, DORC1, p12DOC-1, ST19
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14519
- Gene
- CDK2AP1
- Ensembl
- ENSG00000111328
- Chromosome
- 12
- Canonical length
- 115 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a cyclin-dependent kinase 2 (CDK2) -associated protein which is thought to negatively regulate CDK2 activity by sequestering monomeric CDK2, and targeting CDK2 for proteolysis. This protein was found to also interact with DNA polymerase alpha/primase and mediate the phosphorylation of the large p180 subunit, which suggests a regulatory role in DNA replication during the S-phase of the cell cycle. This protein also forms a core subunit of the nucleosome remodeling and histone deacetylation (NURD) complex that epigenetically regulates embryonic stem cell differentiation. This gene thus plays a role in both cell-cycle and epigenetic regulation. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2012]
Canonical amino-acid sequenceUniProt
115 residues, UniProt reviewed canonical sequence.
>O14519|CDK2AP1
1 MSYKPNLAAH MPAAALNAAG SVHSPSTSMA TSSQYRQLLS DYGPPSLGYT QGTGNSQVPQ
61 SKYAELLAII EELGKEIRPT YAGSKSAMER LKRGIIHARG LVRECLAETE RNARSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDK2AP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 431 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 431 nTPM
- midbrain: 336 nTPM
- hippocampal formation: 251 nTPM
- amygdala: 243 nTPM
- basal ganglia: 238 nTPM
- hypothalamus: 229 nTPM
Single-cell type
- megakaryocytes: 569 nCPM
- platelets: 308 nCPM
- late spermatids: 264 nCPM
- breast myoepithelial cells: 208 nCPM
- müller glia: 207 nCPM
- breast secretory cells: 191 nCPM
Immune cell
- non-classical monocyte: 177 nTPM
- intermediate monocyte: 153 nTPM
- myeloid DC: 53 nTPM
- classical monocyte: 45 nTPM
- total PBMC: 30 nTPM
- eosinophil: 21 nTPM
Brain region
- medulla oblongata: 262 nTPM
- spinal cord: 255 nTPM
- white matter: 237 nTPM
- hypothalamus: 212 nTPM
- cerebellum: 204 nTPM
- thalamus: 188 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.86
- gnomAD pLI
- 0.45
- gnomAD missense Z
- 1.42
- DepMap mean gene effect
- -0.18
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA-templated DNA replication
- positive regulation of protein phosphorylation
- regulation of transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDK2AP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDK2AP1 as an antibody target. Whether an autoantibody or antibody against CDK2AP1 could matter depends on whether native CDK2AP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDK2AP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDK2AP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...